Menopause [phsf]
Affect [menp]
Plasma viscosity [lbpr]
Plasma [bdsu]
Thromboxane [bacs, eico]
Levels [qlco]
Doppler [diap]
findings [ftcn]
objectives [inpr]
Evaluate [ftcn]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Women [popg]
Menopause [phsf]
Compared [acty]
Women [popg]
postmenopausal [tmco]
Thromboxane B2 [eico]
Levels [qlco]
Plasma viscosity [lbpr]
Doppler [diap]
Flow [npop]
Parameters [fndg]
Uterine [bpoc]
internal carotid [bpoc]
Eye [bpoc]
Bladder Wall [bpoc]
Arteries [bpoc]
Methods [inpr]
Five [qnco]
Normal weight [fndg]
Body Mass Index [diap]
kg-m [qnco]
postmenopausal [tmco]
Women [popg]
Age [orga]
Standard deviation [qnco]
Study [mnob]
divided [ftcn]
Group [idcn]
Group I [inpr]
N NOS [aapp, imft]
Menopause [phsf]
Group [idcn]
Ii [aapp]
N NOS [aapp, imft]
Menopause [phsf]
Patients [podg]
treated [topp]
Continuous [idcn]
Estradiol [horm, phsu, strd]
Supplementation [topp]
Courses [tmco]
medroxyprogesterone acetate [horm, phsu, strd]
2 Months [tmco]
Study [mnob]
baseline [bodm]
months [tmco]
Estrogen [horm, phsu, strd]
Phase [tmco]
Cycle [tmco]
Hormone [horm]
Substitution [idcn]
months [tmco]
therapy [ftcn]
baseline [bodm]
Plasma viscosity [lbpr]
Group [idcn]
Decreased [qnco]
therapy [ftcn]
Group I [inpr]
Group [idcn]
Ii [aapp]
Plasma [bdsu]
Thromboxane B2 [eico]
baseline [bodm]
Diminished [qnco]
Group I [inpr]
Group [idcn]
Ii [aapp]
treatment [ftcn]
Doppler [diap]
Assessment [hlca]
Pulsatility index [clna]
Uterine [bpoc]
internal carotid [bpoc]
Eye [bpoc]
Bladder Wall [bpoc]
Arteries [bpoc]
Group [idcn]
baseline [bodm]
Revealed [qlco]
reduction [npop]
Vascular impedance [orgf]
End [spco]
treatment [ftcn]
Group [idcn]
Conclusions [idcn]
Menopause [phsf]
Affect [menp]
Hemodynamic [ortf]
Benefits [qnco]
Hormone replacement therapy [topp]
Normal weight [fndg]
Women [popg]
